Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Thyroid Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Melanoma 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Blood Specimen Collection 11Radiosurgery 7Early Intervention, Educational 5Surveys and Questionnaires 4Standard of Care 4Sentinel Lymph Node Biopsy 4Practice Guidelines as Topic 4Methods 4Indocyanine Green 4Educational Status 4Surgical Procedures, Operative 3Nivolumab 3Ipilimumab 3Immunotherapy 3Cognitive Behavioral Therapy 3Biopsy 3pembrolizumab 2montanide ISA 51 2aldesleukin 2X-Rays 2Tomography, X-Ray Computed 2Tomography, Emission-Computed 2Radiotherapy 2Radiation 2Positron-Emission Tomography 2Palliative Care 2Magnetic Resonance Spectroscopy 2Interviews as Topic 2Interleukin-2 2In Situ Hybridization, Fluorescence 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Melanoma × Reverse Transcriptase Polymerase Chain Reaction × Clear all
NCT00004153 2013-09-05

Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma

University of Chicago

Phase NA Completed
106 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡